Meeting Highlights
Miami, March 27, 2009
Maui, January 14-17, 2009
San Francisco, October 24-29, 2008
Paris, June 11-14, 2008
Chicago, April 10, 2008
San Francisco, March 5-9, 2008
MSK Report News
Thursday, March 11, 2010 BioPharm Business News and Perspectives: AstraZeneca in a Deal with Torrent Pharmaceuticals to Market Generics
The UK drugmaker will market 18 of Torrent's drugs in 9 emerging economies, marking AstraZeneca's first generic-drug partnership...
Wednesday, March 10, 2010 Procedures: Anti-Nausea Drug Eases Bone Marrow Transplants
Aprepitant, taken in combination with other anti-nausea drugs, can significantly ease the experience of a bone marrow transplant, which generally causes severe nausea and vomiting...
Wednesday, March 03, 2010 Pain: Patients Speak Out About the Pain of Fibromyalgia
Sometimes the best way to learn about a disease is to listen to the patients who suffer from it...
Thursday, February 25, 2010 Arthritis: Physical Inactivity and Obesity Raises Arthritis Risk, Especially in Women
Arthritis rates are higher in the US than in Canada, according to a new study...
Wednesday, February 17, 2010 BioPharm Business News and Perspectives: AstraZeneca to Enter the RA Market
AstraZeneca is entering the rheumatoid arthritis (RA) market by gaining rights to Rigel’s RA drug...
Thursday, February 11, 2010 BioPharm Business News and Perspectives: Merck Settles Vioxx Lawsuits
Merck & Co. has agreed to settle lawsuits over their withdrawn painkiller Vioxx with a strengthening of safety procedures, change of leadership, and payment of legal fees...
Wednesday, February 10, 2010 Imaging: FDA Wants to Reduce Radiation Exposure from Medical Scans
Widespread use of CT scans and fluoroscopy is exposing some patients to unnecessary amounts of radiation, and raising their risk of cancer...
Tuesday, February 09, 2010 Procedures: Minimally Invasive Hip Replacements Growing in Popularity
Orthopedic surgeons have developed techniques to make hip replacement operations less invasive, cutting down the length of time patients spend in the hospital and speeding up total recovery time...
Tuesday, February 02, 2010 BioPharm Business News and Perspectives: UCB to Exit the Primary Care Market in the US
Instead, the company plans to focus on becoming a patient-centric global biopharmaceutical leader...
Monday, February 01, 2010 BioPharm Business News and Perspectives: CP-690,550, Pfizer's Oral JAK Inhibitor, Demonstrates Response in Patients with Active Rheumatoid Arthritis
Pfizer’s oral JAK Inhibitor CP-690,550 shows efficacy at improving the pain, function, and health status of RA patients...